Effect of High-fiber Supplement in Multiple Sclerosis
Latest Information Update: 20 Dec 2024
At a glance
- Drugs NBT-NM108 (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
Most Recent Events
- 17 Dec 2024 Status changed from recruiting to completed.
- 15 Nov 2023 Planned End Date changed from 30 Sep 2023 to 30 Sep 2024.
- 15 Nov 2023 Planned primary completion date changed from 30 Sep 2022 to 30 Jun 2024.